UniProt ID | SAE1_HUMAN | |
---|---|---|
UniProt AC | Q9UBE0 | |
Protein Name | SUMO-activating enzyme subunit 1 | |
Gene Name | SAE1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 346 | |
Subcellular Localization | Nucleus . | |
Protein Description | The heterodimer acts as an E1 ligase for SUMO1, SUMO2, SUMO3, and probably SUMO4. It mediates ATP-dependent activation of SUMO proteins followed by formation of a thioester bond between a SUMO protein and a conserved active site cysteine residue on UBA2/SAE2.. | |
Protein Sequence | MVEKEEAGGGISEEEAAQYDRQIRLWGLEAQKRLRASRVLLVGLKGLGAEIAKNLILAGVKGLTMLDHEQVTPEDPGAQFLIRTGSVGRNRAEASLERAQNLNPMVDVKVDTEDIEKKPESFFTQFDAVCLTCCSRDVIVKVDQICHKNSIKFFTGDVFGYHGYTFANLGEHEFVEEKTKVAKVSQGVEDGPDTKRAKLDSSETTMVKKKVVFCPVKEALEVDWSSEKAKAALKRTTSDYFLLQVLLKFRTDKGRDPSSDTYEEDSELLLQIRNDVLDSLGISPDLLPEDFVRYCFSEMAPVCAVVGGILAQEIVKALSQRDPPHNNFFFFDGMKGNGIVECLGPK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MVEKEEAG -------CCCHHCCC | 8.73 | 22814378 | |
2 | Acetylation | ------MVEKEEAGG ------CCCHHCCCC | 16.88 | 19413330 | |
12 | Phosphorylation | EEAGGGISEEEAAQY HCCCCCCCHHHHHHH | 42.08 | 19664994 | |
19 | Phosphorylation | SEEEAAQYDRQIRLW CHHHHHHHHHHHHHH | 14.36 | 28985074 | |
24 | Methylation | AQYDRQIRLWGLEAQ HHHHHHHHHHCHHHH | 18.95 | 115919413 | |
32 | 2-Hydroxyisobutyrylation | LWGLEAQKRLRASRV HHCHHHHHHHHHHHH | 61.52 | - | |
32 | Ubiquitination | LWGLEAQKRLRASRV HHCHHHHHHHHHHHH | 61.52 | 21890473 | |
32 | Ubiquitination | LWGLEAQKRLRASRV HHCHHHHHHHHHHHH | 61.52 | 21890473 | |
32 | Acetylation | LWGLEAQKRLRASRV HHCHHHHHHHHHHHH | 61.52 | 25953088 | |
37 | Phosphorylation | AQKRLRASRVLLVGL HHHHHHHHHHHHHCC | 19.25 | - | |
45 | Ubiquitination | RVLLVGLKGLGAEIA HHHHHCCHHHHHHHH | 46.27 | 21890473 | |
45 | 2-Hydroxyisobutyrylation | RVLLVGLKGLGAEIA HHHHHCCHHHHHHHH | 46.27 | - | |
53 | Ubiquitination | GLGAEIAKNLILAGV HHHHHHHHHHHHHCC | 58.93 | 21890473 | |
53 | Ubiquitination | GLGAEIAKNLILAGV HHHHHHHHHHHHHCC | 58.93 | 21890473 | |
61 | Ubiquitination | NLILAGVKGLTMLDH HHHHHCCCCEEECCC | 47.49 | 21890473 | |
65 | Sulfoxidation | AGVKGLTMLDHEQVT HCCCCEEECCCCCCC | 5.07 | 30846556 | |
86 | Phosphorylation | QFLIRTGSVGRNRAE CEEEECCCCCCCHHH | 22.30 | 27067055 | |
95 | Phosphorylation | GRNRAEASLERAQNL CCCHHHHHHHHHHHC | 23.44 | 22210691 | |
105 | Sulfoxidation | RAQNLNPMVDVKVDT HHHHCCCCCEEEECH | 3.80 | 21406390 | |
109 | Sumoylation | LNPMVDVKVDTEDIE CCCCCEEEECHHHHH | 29.90 | - | |
109 | Ubiquitination | LNPMVDVKVDTEDIE CCCCCEEEECHHHHH | 29.90 | 21906983 | |
109 | Sumoylation | LNPMVDVKVDTEDIE CCCCCEEEECHHHHH | 29.90 | - | |
141 | Ubiquitination | CSRDVIVKVDQICHK CCCCEEEEHHHHHHC | 29.04 | - | |
141 | Acetylation | CSRDVIVKVDQICHK CCCCEEEEHHHHHHC | 29.04 | 25953088 | |
148 | Ubiquitination | KVDQICHKNSIKFFT EHHHHHHCCCCEEEE | 48.23 | - | |
150 | Phosphorylation | DQICHKNSIKFFTGD HHHHHCCCCEEEECC | 31.77 | - | |
152 | Ubiquitination | ICHKNSIKFFTGDVF HHHCCCCEEEECCCC | 33.96 | - | |
178 | Ubiquitination | EHEFVEEKTKVAKVS CCHHHHCHHHEEEHH | 39.89 | - | |
180 | Ubiquitination | EFVEEKTKVAKVSQG HHHHCHHHEEEHHHC | 51.79 | - | |
183 | Ubiquitination | EEKTKVAKVSQGVED HCHHHEEEHHHCCCC | 45.46 | 21890473 | |
185 | Phosphorylation | KTKVAKVSQGVEDGP HHHEEEHHHCCCCCC | 22.10 | 17525332 | |
194 | Phosphorylation | GVEDGPDTKRAKLDS CCCCCCCCCCCCCCC | 26.09 | 20068231 | |
195 | Ubiquitination | VEDGPDTKRAKLDSS CCCCCCCCCCCCCCC | 58.71 | 21890473 | |
195 | Acetylation | VEDGPDTKRAKLDSS CCCCCCCCCCCCCCC | 58.71 | 25953088 | |
195 | Sumoylation | VEDGPDTKRAKLDSS CCCCCCCCCCCCCCC | 58.71 | - | |
198 | Ubiquitination | GPDTKRAKLDSSETT CCCCCCCCCCCCCCC | 57.78 | - | |
198 | Acetylation | GPDTKRAKLDSSETT CCCCCCCCCCCCCCC | 57.78 | 23749302 | |
201 | Phosphorylation | TKRAKLDSSETTMVK CCCCCCCCCCCCEEE | 40.28 | 29255136 | |
202 | Phosphorylation | KRAKLDSSETTMVKK CCCCCCCCCCCEEEE | 38.33 | 29255136 | |
204 | Phosphorylation | AKLDSSETTMVKKKV CCCCCCCCCEEEEEE | 23.34 | 29255136 | |
205 | Phosphorylation | KLDSSETTMVKKKVV CCCCCCCCEEEEEEE | 18.86 | 29255136 | |
206 | Sulfoxidation | LDSSETTMVKKKVVF CCCCCCCEEEEEEEE | 5.62 | 21406390 | |
208 | Ubiquitination | SSETTMVKKKVVFCP CCCCCEEEEEEEEEE | 35.73 | 21906983 | |
208 | 2-Hydroxyisobutyrylation | SSETTMVKKKVVFCP CCCCCEEEEEEEEEE | 35.73 | - | |
209 | Ubiquitination | SETTMVKKKVVFCPV CCCCEEEEEEEEEEH | 39.11 | - | |
210 | Ubiquitination | ETTMVKKKVVFCPVK CCCEEEEEEEEEEHH | 37.60 | - | |
217 | Ubiquitination | KVVFCPVKEALEVDW EEEEEEHHHHHCCCC | 23.55 | - | |
228 | Ubiquitination | EVDWSSEKAKAALKR CCCCCHHHHHHHHHH | 58.07 | 21890473 | |
228 | 2-Hydroxyisobutyrylation | EVDWSSEKAKAALKR CCCCCHHHHHHHHHH | 58.07 | - | |
228 | Acetylation | EVDWSSEKAKAALKR CCCCCHHHHHHHHHH | 58.07 | 23236377 | |
230 | Ubiquitination | DWSSEKAKAALKRTT CCCHHHHHHHHHHHC | 45.30 | - | |
236 | Phosphorylation | AKAALKRTTSDYFLL HHHHHHHHCCHHHHH | 29.12 | 24719451 | |
236 (in isoform 2) | Phosphorylation | - | 29.12 | 23663014 | |
237 (in isoform 2) | Phosphorylation | - | 24.51 | 23663014 | |
238 | Phosphorylation | AALKRTTSDYFLLQV HHHHHHCCHHHHHHH | 29.69 | 23403867 | |
238 (in isoform 2) | Phosphorylation | - | 29.69 | 23663014 | |
240 | Phosphorylation | LKRTTSDYFLLQVLL HHHHCCHHHHHHHHH | 8.90 | 23403867 | |
240 (in isoform 2) | Phosphorylation | - | 8.90 | 23663014 | |
246 (in isoform 2) | Phosphorylation | - | 2.51 | 23663014 | |
248 (in isoform 2) | Phosphorylation | - | 28.74 | 23663014 | |
262 | Phosphorylation | RDPSSDTYEEDSELL CCCCCCCCHHHHHHH | 23.47 | - | |
266 | Phosphorylation | SDTYEEDSELLLQIR CCCCHHHHHHHHHHH | 33.16 | - | |
283 | Phosphorylation | VLDSLGISPDLLPED HHHHCCCCCCCCCHH | 15.57 | 28348404 | |
288 (in isoform 3) | Phosphorylation | - | 46.54 | - | |
291 (in isoform 3) | Phosphorylation | - | 3.00 | - | |
294 | Phosphorylation | LPEDFVRYCFSEMAP CCHHHHHHHHHHHHH | 7.79 | 23532336 | |
299 (in isoform 3) | Phosphorylation | - | 5.04 | - | |
335 | Ubiquitination | FFFFDGMKGNGIVEC EEECCCCCCCCCEEC | 55.54 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SAE1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SAE1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SAE1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SAE2_HUMAN | UBA2 | physical | 17353931 | |
SUMO3_HUMAN | SUMO3 | physical | 17353931 | |
UNC79_HUMAN | UNC79 | physical | 17353931 | |
CP1B1_HUMAN | CYP1B1 | physical | 17353931 | |
SAE2_HUMAN | UBA2 | physical | 10217437 | |
SAE2_HUMAN | UBA2 | physical | 10187858 | |
ETV4_HUMAN | ETV4 | physical | 19307308 | |
SAE2_HUMAN | UBA2 | physical | 9920803 | |
A4_HUMAN | APP | physical | 21832049 | |
SAE2_HUMAN | UBA2 | physical | 22939629 | |
UBC9_HUMAN | UBE2I | physical | 12641448 | |
SYAC_HUMAN | AARS | physical | 22863883 | |
PUR8_HUMAN | ADSL | physical | 22863883 | |
DHYS_HUMAN | DHPS | physical | 22863883 | |
LPP_HUMAN | LPP | physical | 22863883 | |
PDE12_HUMAN | PDE12 | physical | 22863883 | |
RAGP1_HUMAN | RANGAP1 | physical | 22863883 | |
TPD54_HUMAN | TPD52L2 | physical | 22863883 | |
WDR4_HUMAN | WDR4 | physical | 22863883 | |
SNUT2_HUMAN | USP39 | physical | 25027693 | |
HSP72_HUMAN | HSPA2 | physical | 25027693 | |
UBC9_HUMAN | UBE2I | physical | 19250909 | |
SUMO3_HUMAN | SUMO3 | physical | 26344197 | |
TYSY_HUMAN | TYMS | physical | 26344197 | |
CATC_HUMAN | CTSC | physical | 26496610 | |
SUMO2_HUMAN | SUMO2 | physical | 26496610 | |
GDF15_HUMAN | GDF15 | physical | 26496610 | |
SAE2_HUMAN | UBA2 | physical | 26496610 | |
PQBP1_HUMAN | PQBP1 | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-185, AND MASSSPECTROMETRY. |